Clinical relevance of Helicobacter pylori CagA-positive strains: Gastroduodenal peptic lesions marker

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 3, 2000, Pages 167-173

  Martín Guerrero, Juan Manuel ^a,b   Hergueta Delgado, P ^a   Esteban Carretero, J ^c   Romero Castro, R ^a   Pellicer Bautista, F J ^a   Herrerias Gutierrez J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b c/ Esperanza de la Trinidad   (Spain)

^c NONE

Author keywords

CagA phenotype; Duodenal ulcer; Gastric ulcer; Helicobacter pylori; Peptic ulcer; VacA phenotype

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DUODENITIS; DUODENOSCOPY; DUODENUM ULCER; FEMALE; GASTRITIS; GASTROSCOPY; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PEPTIC ULCER; PHENOTYPE; STOMACH ULCER; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; DUODENAL ULCER; DUODENITIS; DUODENOSCOPY; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PHENOTYPE; STOMACH ULCER;

EID: 0034149922     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Isenberg JI, McQuaid KR, Laine L, Walsh JH. Acid-peptic disorders. En: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, eds. Textbook of Gastroenterology, Vol.1. Philadelphia: JB Lippincott; 1995. p. 1347-430.
2. Carrick J, Daskalopoulos G, Mitchell H, et al. Succesfull eradication of Helicobacter pylori infection prevents recurrence of duodenal ulceration. Rev Esp Enferm Dig 1990; 78(Supl 1):129.
3. Graham DY, Lew GM, Klein PD, Evans DG, Saeed ZA. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: A randomised, controlled study. Ann Intern Med 1992;116:705-8.
4. Labenz J, Rühl GH, Bertrams J, Börsch G. Clinical course of duodenal ulcer disease one year after omeprazole plus amoxycilin or triple therapy plus ranitidine for cure Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994; 6:294-7.
5. Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow up. Lancet 1994;343:258-61.
6. Guslandi M. More about refractory duodenal ulcers. Gut 1984;25:1433-4.
7. Labenz J, Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994;55:19-23.
8. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;321:717-27.
9. Tytgat GNJ, Axon ATR, Dixon MF. Helicobacter pylori: Causal agent in peptic ulcer disease? Sidney: Working Paarty Reports; 1990. p. 36.
10. Feng YY, Wang Y. Campylobacter pylori in patients with gastritis, peptic ulcer, and carcinoma of the stomach in Lanzhou, China. Lancet 1988;i:1055-6.
11. Tytgat GNJ, Noack LA, Rauws EAJ. Helicobacter pylori infection and duodenal ulcer disease. In: Dooley CP, Cohen H, eds. Gastroenterol Clin North Am. Philadelphia: WB Saunders; 1993. p. 127-39.
12. Correa P, Yardley JH. Grading and classification of chronic gastritis: One American response to the Sydney System. Gastroenteroly 1992;102:355-9.
13. Befritts R, Granström M, Rylander M, Rubio C. Helicobacter pylori in 205 consecutive endoscopy patients. Scand J Infect Dise 1993;25:185-91.
14. Boixeda D, Gisbert JP, Cantón R, et al. Helicobacter pylori, úlcera gástrica y antiinflamatorios no esteroideos. Med Clin (Barc) 1996;106:209-12.
15. Freston JW. Mechanisms of relapse in peptic ulcer disease. J Clin Gastroenterol 1989;1(Supl 1):S34-S8.
16. Tatsuta M, Lishi H. Yokota Y. Effects of Helicobacter pylori infection on healing and recurrence of gastric ulcers. Am J Gastroenterol 1995;90:406-10.
17. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cvtotoxic activity in broth culture filtrates of Campylobacter pylori. J Med Microbiol 1988;26:93-9.
18. Hupertz V, Czinn S. Demonstration of a cytotoxin from Campylobacter pylori. Eur J Clin Microbiol Infct Dis 1988; 7:576-8.
19. Figura N, Guglielmetti P, Rossolini A, Barbieri A, Gusi G, Musmanno RA, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis anly. J Clin Microbiol 1989;27:225-6.
20. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992;267:1570-5.
21. Eaton KA, Morgan DR, Krakrowka S. Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun 1989;57:1119-25.
22. Phadnis S, Ilver D, Janzon C, Normark S, Westblom TU. Pathological significance and molecular characterization of the vacuolating toxin gen of Helicobacter pylori. Infect Immun 1994;62:1565-75.
23. Tummuru MK, Cover TL, Blaser MJ. Clonning and expression of a high-molecular-mass antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993;61 1799-809.
24. Tummuru MK, Cover TL, Blaser MJ. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun 1994;62:2609-13.
25. Maratka Z. Gastroscopia. En: Terminología, definición y criterios diagnósticos en endoscopia digestiva. Ed. Españo-la. NORMED-Verlag; 1986.
26. Gisbert JP, Boixeda de Miquel M, Martín de Argila C. Infección por Helicobacter pylori y úlcera péptica. En: Boixeda de Miquel D, Gisbert JP, Martín de Argila C, eds. Infección por Helicobacter pylori ¿Dónde está el límite? Barcelona: Prous Science; 1996. p. 135-57.
27. Atherton JC, Coa P, Peek RM Jr, Tummuru MKR, Blasei MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270:17771-7.
28. Stephens JC, Stewart JA, Folwell AM, Rathbone BJ. Helicobacter pylori cagA status, vacA genotypes and ulcer disease. Eur J Gastroenterol Hepatol 1998;10(5):381-4.
29. Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A, Galle PR, et al. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol 1998;36:944-8.
30. van Doom LJ, Figueiredo C, Rossau R, Jannes G, van Asbroek M, et al. Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol 1998;36:1271-6.
31. Go MF, Small SM, Graham DY. Lack of an association of VacA genotype and duodenal ulcer disease. Gut 1996;39 (Supl2):A53.
32. Krämer B, Borchers S, Soutschek E, Lehn N. Use of recombinant VacA in Immunoblot diagnostics. European Helicobacter pylori Study Group. XIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 1997;41(Supl 1):A75 (8/272).
33. Go MF, Cissell L, Graham DY. Failure of VacA genotype of to correlate with type of gastroduodenal disease. European Helicobacter pylori Study Group. XIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 1997;41(Supl 1):A110 (10/404).
34. Weel JF, van der Hulst RW, Gerrits Y, Roorda P, Feller M, Dankert J, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996;173:1171-5.
35. Takata T, Fujimoto S, Anzai K, Shirotani T, Okada M, Sawae Y, et al. Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia. Am J Gastroenterol 1998;93:30-4.
36. Kodama K, Fujioka T, Ito A, Kubota T, Murakami K, Nasu M. Expression of vacuolating cytotoxin in clinical isolates of Helicobacter pylori. J Gastroenterol 1996;31(Supl 9):9-11.
37. España Contreras MP, Huelín Benítez J, De la Cruz Lombardo J. Etiopatogenia y fisiopatología de la infección por Helicobacter pylori. En: España Contreras MP, Huelín Benítez J, De la Cruz Lombardo J, eds. 1996 Helicobacter pylori. Un paso más. Barcelona: Prous Science; 1997. p. 5-21.
38. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995;33:1203-5.
39. Pilotto A, Rassu M, Franceschi M, Bozzola L, Furlan F, Scagnelli M, et al. CagA-positive Helicobacter pylori infection in the elderly: Association with gastric ulcer, gastric atrophy and intestinal metaplasia. European Helicobacter pylori Study Group. XIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 1997; 41(Supl 1):A30 (2/109).
40. Fusconi M, Farinelli S, Menegatti M, Figura N, Landi F, Quan S, et al. Western immunoblttiong (WB) and a recombinant assay (RIBA) for detection of H. pylori (Hp) anti Cag-A reactivity (anti-HP Cag-A). European Helicobacter pylori Study Group. XIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 1997; 41(Supl 1):A73 (8/264).
41. Queiroz DMM, Mendes EN, Nogueira AMMF, Carvalho AST, Rocha GA, Magalháes PP. CagA status in H. pylori positive children with and without duodenal ulcer: a histopathological study. European Helicobacter pylori Study Group. XIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 1997;41(Supl 1):A16 (2/47).
42. Takata T, Okada M, Shirotani T, Anzai K, Ono J, Fujimoto S. CagA, VacA and VacA genotypes in the isolates from patients with either peptic ulcers or nonulcer dyspepsia. European Helicobacter pylori Study Group. XIth International Workshop on Gastroduodenal Pathology and Helicobacler pylori. Gut 1997;41(Supl 1):A111 (10/40).
43. Mendes EN, Queiroz DMM, Magalháes PP, Rocha GA, Nogueira AMMF, Oliveira AMR, et al. CagA in H. pylori strains isolated from patients with gastric lymphoma and carcinoma, duodenal ulcer and gastritis in a developing country. European Helicobacter pylori Study Group. XIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 1997;41(Supl 1):A113 (10/417).
44. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Pérez-Pérez GI, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol 1995;33:1496-500.
45. Pan ZJ, van der Hulst RW, Feller M, Xiao SD, Tytgat GN, Dankert J, et al. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 1997;35:1344-7.
46. Miehlke S, Kibler K, Kim JG, Figura N, Small SM, Graham DY, Go MF. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol 1996;91:1322-5.
47. Maeda S, Kanai F, Ogura K, Yoshida H, Ikenoue T, Takahashi M, et al. High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan. Dig Dis Sci 1997;42: 1841-7.
48. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998;42:338-43.
49. Owen RJ, Hurtado A, Banatvala N, Abdi Y, Davies GR, Feldman R, et al. Conservation of the cytotoxin-associated (cagA) gene of Helicobacter pylori and investigation of association with vacuolating-cytotoxin activity and gastroduodenal disease. FEMS Immunol Med Microbiol 1994; 9:307-15.
50. Orsini B, Ciancio G, Surrenti E. Macri G, Biagini MR, Milani S, et al. Serologic detection of CagA positive Helicobacter pylori infection in a Northern Italian population: its association with peptic ulcer disease. Helicobacter 1998; 3:15-20.
51. Ito A, Fujioka T, Kodama K, Nishizono A, Nasu M. Virulence-associated genes as markers of strain diversity in Helicobacter pylori infection. J Gastroenterol Hepatol 1997;12:666-9.
52. Vaira D, Fusconi M, Menegatti M, Quan S, Farinelli S, Landi F, et al. A novel recombinant immunoblotting assay (RIBA) for determination of serological reactivities of Helicobacter pylori (Hp). European Helicobacter pylori Study Group. Xith International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 1997;41 (Supl 1):A77 (8/278).
53. Hazell SL, Mitchell HM, Hu PJ, Li YY. Markers of Helicobacter pylori infection in gastric cancer patients. VIIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Houston 1994 (Abstract).
54. Peek RM, Milier GG, Tham KT, Pérez-Pérez GI, Zhao X, Atherton JC, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Laboratory Investigation 1995;71:760-70.
55. Domingo D, Alarcon T, Sánchez Romero I, Sanz JC, López-Brea M. Distribution of cagA gene in Helicobacter pylori Spanish clinical isolates. European Helicobacter pylori Study Group. XIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Gut 1997;41(Supl 1):A114 (10/421).
56. Glupczvnski Y, Van den Borre C, Butzler JP, Burette A. Evaluation of bioblot Helicobacter, a new commercial western blot test for the serological diagnosis of Helicobacter pylori infection. Edinburg 1995, VIIIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. (Abstract).